Complete immunotolerance induction after FEIBA prophylaxis in a haemophilia A patient with high-titre inhibitor

Haemophilia

Volumn 18, Issue 3, 2012, Pages

  Nanishi, E ^a   Ohga, Shouichi ^a   Doi, T ^a   Ishimura, M ^a   Ihara, K ^a   Takada, H ^a   Shima, M ^b   Hara, T ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 COMPLEX; CROSSEIGHT M; PROPLEX ST; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; UNCLASSIFIED DRUG;

ADULT; BLEEDING; BRAIN HEMORRHAGE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG MEGADOSE; HEMOPHILIA A; HUMAN; IMMUNOLOGICAL TOLERANCE; LETTER; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; PROPHYLAXIS;

BLOOD COAGULATION FACTOR INHIBITORS; BLOOD COAGULATION FACTORS; COAGULANTS; FACTOR VIII; HEMOPHILIA A; HEMORRHAGE; HUMANS; IMMUNE TOLERANCE; MALE; YOUNG ADULT;

EID: 84860334409     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2012.02776.x     Document Type: Letter

References (10)

1. DiMichele D. Immune tolerance induction in haemophilia: evidence and the way forward. J Thromb Haemost 2011; 9(Suppl 1): 216-25.
2. Ohga S, Nomura A, Takada H, Suga N, Hara T. Successful self-infusion of activated prothrombin complex concentrate for prophylaxis in a child with a factor VIII inhibitor. Am J Hematol 2007; 82: 145-9.
3. Shima M, Sawamoto Y, Nakai H et al. Measurement of anti-factor VIII IgG, IgG4 and IgM alloantibodies in previously untreated haemophilia A patients treated with recombinant factor VIII. Kogenate Japanese Clinical Study Group. Int J Hematol 1995; 62: 35-43.
4. Watanabe T, Watanabe H, Onishi T, Okamura K, Kgami S, Yamada T et al. Reduction of anti-FIX inhibitor titre in a haemophilia B patient with continuous use of activated prothrombin complex concentrate. J Thromb Haemost 2007; 5(Suppl 2): P-W-154 Abstract (XXIst ISTH Congress, August 2007)
5. Yoshioka A, Kamisue S, Tanaka I, Kato M, Kohmura I, Shima M et al. Anamnestic response following infusion of prothrombin complex concentrates (PCC) and activated prothrombin complex concentrates (APCC) in haemophilia A patients with inhibitors. Blood Coagul Fibrinolysis 1991; 2(Suppl 1): 51-58.
6. Jiménez-C V, Alvarez MT, Martín-Salces M et al. Prophylaxis in 10 patients with severe haemophilia A and inhibitor: different approaches for different clinical situations. Haemophilia 2009; 15: 203-9.
7. Holme PA, Glomstein A, Grønhaug S, Tjønnfjord GE. Home treatment with bypassing products in inhibitor patients: a 7.5-year experience. Haemophilia 2009; 15: 727-32.
8. Valentino LA. Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitors. Haemophilia 2010; 16: 263-71.
9. Lin PC, Liao YM, Tsai SP, Chang TT. Immune tolerance induction therapy for patients with haemophilia A and FVIII inhibitors particularly using low-dose regimens. Pediatr Blood Cancer 2011; 57: 1029-33.
10. Kurnik K, Bidlingmaier C, Engl W, Chehadeh H, Reipert B, Auerswald G. New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor development. Haemophilia 2010; 16: 256-62.